Oxurion Issues EUR 2.0 million in Bonds for Tranche 2 of the Funding Program with Atlas Special Opportunities LLC mei 22, 20230OpmerkingenEN Read More
Oxurion Receives Transparency Notification from Atlas Special Opportunities LLC mei 19, 20230OpmerkingenEN NL Read More
Oxurion Announces Results of the Annual Shareholders’ Meeting of 2 May 2023 mei 15, 20230OpmerkingenEN Read More
Oxurion Receives Transparency Notifications from Atlas Special Opportunities LLC mei 12, 20230OpmerkingenEN NL Read More
Information on the Total Number of Voting Rights (Denominator) following Conversion Notice from ATLAS mei 12, 20230OpmerkingenEN NL Read More
Information on the Total Number of Voting Rights (Denominator) following Conversion Notice from ATLAS mei 5, 20230OpmerkingenEN NL Read More
Oxurion Receives Transparency Notification from Atlas Special Opportunities LLC mei 3, 20230OpmerkingenEN NL Read More
Information on the Total Number of Voting Rights (Denominator) following Conversion Notice from ATLAS april 28, 20230OpmerkingenEN NL Read More
Oxurion Issues EUR 2.0 million in Bonds for Tranche 1 (B) of the Funding Program with Atlas Special Opportunities LLC april 27, 20230OpmerkingenEN Read More
Oxurion Receives Transparency Notifications from Atlas Special Opportunities LLC april 24, 20230OpmerkingenEN NL Read More
Oxurion Receives Transparency Notification from Atlas Special Opportunities LLC april 14, 20230OpmerkingenEN NL Read More
Information on the Total Number of Voting Rights (Denominator) following Conversion Notice from ATLAS april 7, 20230OpmerkingenEN NL Read More
Information on the Total Number of Voting Rights (Denominator) following Conversion Notice from ATLAS maart 31, 20230OpmerkingenEN NL Read More
Prospectus Nieuwe Aandelen – 29 maart 2023 maart 29, 20230OpmerkingenProspectus voor de toelating tot de handel op Euronext Brussels van maximal 1,885,000,000 nieuwe aandelen Read More
Supplement op het Prospectus d.d. 29 maart 2023 maart 29, 20230OpmerkingenSupplement op het Prospectus d.d. 29 maart 2023 Read More
